Navigation Links
Breast Cancer Drug Might Help Men on Prostate Cancer Therapy
Date:8/28/2012

TUESDAY, Aug. 28 (HealthDay News) -- The breast cancer drug tamoxifen may reduce some of the side effects caused by hormone therapy for prostate cancer, according to a new study.

Androgen-suppression therapy is often used to slow the progression of advanced prostate cancer. But these drugs, which block testosterone activity, can cause side effects such as breast enlargement and pain that may stop men from using this treatment.

German researchers examined the results of four independent clinical trials that examined the use of tamoxifen to manage these side effects in prostate cancer patients undergoing androgen-suppression therapy.

The study found that tamoxifen reduced the risk of breast enlargement and breast pain in men at three, six, nine and 12 months of treatment compared to men who did not take tamoxifen. Overall, tamoxifen was more successful in reducing breast symptoms than radiation therapy or treatment with the aromatase inhibitor anastrozole, which is also used to treat breast cancer.

Few of the men treated with tamoxifen stopped taking their medication during their year of treatment. Tamoxifen caused no significant side effects, according to the researchers.

The study appeared online Aug. 27 in the journal BMC Medicine.

"Not all men will suffer [breast enlargement] during anti-androgen therapy. However, if men know that there is a successful option for reducing the breast symptoms associated with treatment for prostate cancer, they may be more likely to see their doctor when symptoms of cancer first appear, and consequently reduce the number of unnecessary deaths," study leader Dr. Frank Kunath said in a journal news release.

More information

The American Urological Association has more about hormone therapy for prostate cancer.

-- Robert Preidt

SOURCE: BMC Medicine, news release, Aug. 27, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Daily Aspirin May Help Fight Prostate Cancer, But Not Breast Cancer
2. Excess Pounds Raise Risk of Breast Cancer Recurrence, Death: Study
3. Johns Hopkins team finds ICU misdiagnoses may account for as many annual deaths as breast cancer
4. Lack of sleep found to be a new risk factor for aggressive breast cancers
5. Obese and overweight women face increased risk of recurrence of most common type of breast cancer
6. RI Hospital researcher: Older women may not benefit from radiotherapy after breast surgery
7. New survey: Women want to SEE breast reconstruction results before cancer surgery
8. Breast density does not influence breast cancer death among breast cancer patients
9. Dense Breasts Not Linked to Cancer Deaths
10. Breast-Milk Compound May Shield Babies From HIV
11. Added benefit of eribulin in breast cancer is not proven
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast Cancer Drug Might Help Men on Prostate Cancer Therapy
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
Breaking Medicine Technology: